CM Life Sciences, Inc.
CM Life Sciences, Inc. intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses. The company was founded in 2020 and is based in New York, New York.
Shell Companies
US, New York [HQ]
Ratios
2 Records · Starting from 2020Margins, Growth Rates In %
| Ratio | 2020 | None | |
|---|---|---|---|
| Profitability | |||
| Gross Margin | - - | - - | |
| Profit Margin | - - | - - | |
| Operating Margin | - - | - - | |
|
EPS Growth
|
- - | - - | |
| EPS USD | -0.35 | - - | |
| Return on Assets (ROA) | -0.04 | - - | |
| Return on Equity (ROE) | -0.04 | - - | |
| Return on Invested Capital (ROIC) | -0.05 | - - | |
| Solvency | |||
| Equity Ratio | - - | - - | |
| Debt/Assets | - - | - - | |
| Debt/Equity | - - | - - | |
| Debt/EBITDA | 569.42 | - - | |
|
Debt/Capitalization
|
- - | - - | |
| Long-Term Debt/Capitalization | - - | - - | |
| Interest Debt per Share USD | - - | - - | |
| Debt Growth | - - | - - | |
| Liquidity | |||
| Current Ratio | 1,412.39 | - - | |
| Quick Ratio | 457,020.83 | - - | |
| Cash Ratio | 1,127.14 | - - | |
| Operating Cash Flow Ratio | - - | - - | |
| Turnover | |||
| Inventory Turnover | - - | - - | |
| Receivables Turnover | - - | - - | |
| Payables Turnover | - - | - - | |
|
Asset Turnover
|
- - | - - | |
| Fixed Turnover | - - | - - | |
| Coverage | |||
| Interest Coverage | - - | - - | |
| Asset Coverage | - - | - - | |
| Cash Flow Coverage (CFGR) | - - | - - | |
| EBITDA Coverage | - - | - - | |
| Dividend Coverage | - - | - - | |
| Time Interest Earned (TIE) | - - | - - | |
| Market Prospects | |||
| Dividend Yield | - - | - - | |
| Earnings Yield | -0.03 | - - | |
|
Price/Earnings (P/E)
|
-3,178.2296 | - - | |
| Price/Earnings Growth (PEG) | - - | - - | |
|
Price/Book (P/B)
|
142.58 | - - | |
| Price/Tangible Book (P/TB) | 142.58 | - - | |
| Price/Sales (P/S) | - - | - - | |
|
Price/Cash Flow (P/CF)
|
- - | - - | |
| Price/Free CF (P/FCF) | - - | - - | |
| Price/Operating CF (P/OCF) | - - | - - |